Election 2014
SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Ranbaxy Laboratories

Ranbaxy Laboratories

BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Apr 23, 17:00
471.00
6.10 (+1.31%)
VOLUME 561,086
AVERAGE VOLUME
5-Day 241,440
10-Day 497,791
30-Day 559,994
VOLUME SHOCKER
5-Day 241,440
10-Day 497,791
30-Day 559,994
Prev. Close
464.90
Open Price
464.00
Bid PRICE (QTY.)
471.00 (814)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 464.00 483.05
52 Wk Low/High 253.95 505.00
LIVE
NSE
Apr 23, 17:00
470.85
5.90 (+1.27%)
VOLUME 3,615,068
AVERAGE VOLUME
5-Day 1,662,750
10-Day 4,221,341
30-Day 3,639,964
VOLUME SHOCKER
5-Day 1,662,750
10-Day 4,221,341
30-Day 3,639,964
Prev. Close
464.95
Open Price
463.55
Bid PRICE (QTY.)
470.85 (2899)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 463.55 483.10
52 Wk Low/High 253.65 490.00
Action in Ranbaxy Laboratories

Ranbaxy Labs
Sentimeter

50%50%
BUYSELL

50% of moneycontrol users recommend buying Ranbaxy Labs. What's your call on Ranbaxy Labs today?
Read 6 investor views

MARKET CAP (Rs Cr)
19,961.25
*P/E
-
*BOOK VALUE (Rs)
3.41
DIV (%)
0.00%
Market Lot
1
INDUSTRY P/E
27.89
*EPS (TTM)
-
*P/C
-
*PRICE/BOOK
138.12
DIV YIELD.(%)
-%
FACE VALUE (Rs)
5.00
DELIVERABLES (%)
32.59 new
DELIVERY AVERAGES
3-Day 39.38%
5-Day 37.24%
8-Day 33.75%
* Based on standalone numbers
Track Ranbaxy Labs on the go with moneycontrol app
UPCOMING CORPORATE ACTION
Board Meeting
on 09-May-2014 (Audited Results)
EXPAND ALL COLLAPSE ALL
Would you bet on Ranbaxy Labs today?
Test your strategy with virtual money on Moneybhai
F&O Quote
Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 453.90 464.00  
High Price 462.70 483.05  
Low Price 450.00 464.00  
Last Price 458.80 471.00 2.66
Volume 77,852 561,086 620.71
Simple Moving Averages
Days BSE NSE
30 399.12 399.24
50 382.34 382.49
150 395.57 395.61
200 386.57 386.58

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Ranbaxy Labs

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
 Consolidated (Dec '13)
(Sep '13)
Net Sales 2,858.96 2,750.17
Other Income 35.24 26.09
PBDIT 151.72 -146.47
Net Profit -158.49 -448.32

Annual Report

Download in PDF format 2011 |2010
Balance Sheet
(Sep '13)
(In Rs Cr)
Total Share Capital 211.46
Net Worth 1922.08
Total Debt 4763.61
Net Block 1993.53
Investments 3131.17
Net Current Assets 1401.38
Total Assets 6685.68
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 626.10 1.09 653.10 481.50 129,675.57
Lupin 987.25 0.52 1012.00 693.70 44,265.90
Dr Reddys Labs 2565.45 0.50 2939.80 1999.40 43,640.58
Cipla 399.65 0.58 450.00 375.00 32,088.75
GlaxoSmithKline 2463.15 -0.95 3054.40 2225.00 20,863.62
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 14Dec' 13Sep' 13Jun' 13
Promoter63.4163.4163.5163.51
FII11.7910.7410.4210.39
DII8.308.819.0410.35
Others16.5017.0417.0315.75
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
A-41, Industrial Area, Phase-VIII-A,,Sahibzada Ajit Singh Nagar
City
Mohali
State
Punjab
Pin Code
160071
Tel. No.
0172-6678666
Fax No.
0172-5013376
REGISTRARS
Name
Alankit Assignment Ltd.
Address
2E/8, Blazeflash House, R T A Division, 1st Floor Jhandewalan Extension,
City
New Delhi - 110055
State
Delhi
Tel. No.
011-51540060, 51540061, 51540062, 51540063
Fax No.
011-51540064
Internet
MANAGEMENT
Name
Designation
Tsutomu Une
Chairman
Arun Sawhney
Managing Director & CEO
Akihiro Watanabe
Director
Anthony H Wild
Director
Kazunori Hirokawa
Additional Director
Message Board & Community

About Ranbaxy Labs

Ranbaxy Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 19,961.25 crore.The company has reported a consolidated sales of Rs 2,858.96 crore and a Net Loss of Rs 158.49 crore for the quarter ended Dec 2013.

The company management includes Tsutomu Une - Chairman, Arun Sawhney - Managing Director & CEO, Akihiro Watanabe - Director, Anthony H Wild - Director, Kazunori Hirokawa - Additional Director, Rajesh V Shah - Director, Takashi Shoda - Director, Percy K Shroff - Director.

It is listed on the BSE with a BSE Code of 500359 and the NSE with an NSE Code of RANBAXY.

Its Registered office is at A-41, Industrial Area, Phase-VIII-A,,Sahibzada Ajit Singh Nagar Mohali,Punjab - 160071.

Their Registrars are Alankit Assignment Ltd.

Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Ranbaxy Labs